Margaretha G.M. Roemer

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy, Chip Stewart, Andrew Dunford et al. · Nature Medicine · 2018 · 2K citations · Full text

Medicine, Hematology, Oncology +12

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

Anas Younes, Armando Santoro, Margaret A. Shipp et al. · The Lancet Oncology · 2016 · 924 citations · Full text

Medicine, Hematology, Oncology +16

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

Benjamin J. Chen, Bjoern Chapuy, Jing Ouyang et al. · Clinical Cancer Research · 2013 · 839 citations

Medicine, Immunology, Oncology +17

Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma

Bjoern Chapuy, Michael R. McKeown, Charles Y. Lin et al. · Cancer Cell · 2013 · 766 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Bjoern Chapuy, Margaretha G.M. Roemer, Chip Stewart et al. · Blood · 2015 · 599 citations · Full text

Medicine, Genetics, Molecular Genetics +16